Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Landiolol for Prevention of Organ Failure in Sepsis
jRCTs031180282Completed
- Start
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of landiolol in sepsis, acute kidney failure (AKF) and multiple organ dysfunction syndrome (MODS). Primary endpoint: Prevention of organ failure progression by SOFA. Started May 2017; status: completed.
02
Drugs
landiolol
03
Conditions
sepsisacute kidney failure (AKF)multiple organ dysfunction syndrome (MODS)
Beyond the preview
Go deeper on jRCTs031180282.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031180282.